Centanafadine sustained-release tablets

centanafadine · Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Centanafadine sustained-release tablets, covering 2021-05-05 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder [Phase 3]

See pricing